Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia.
about
From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric DisordersSniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapyEndogenous peripheral oxytocin measures can give insight into the dynamics of social relationships: a reviewIntranasal oxytocin effects on social cognition: a critiqueA double-blind randomized controlled trial of oxytocin nasal spray and social cognition training for young people with early psychosisA Role for Oxytocin in the Etiology and Treatment of Schizophrenia.Oxytocin in schizophrenia: a review of evidence for its therapeutic effects.Oxytocin enhances attention to the eye region in rhesus monkeys.Potential of Oxytocin in the Treatment of SchizophreniaOxytocin-augmented social cognitive skills training in schizophrenia.The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findingsReduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders.Role of oxytocin signaling in the regulation of body weight.Association between oxytocin receptor gene polymorphisms and self-rated 'empathic concern' in schizophrenia.Long-term exposure to intranasal oxytocin in a mouse autism model.Developmental perspectives on oxytocin and vasopressin.Oxytocin administration enhances controlled social cognition in patients with schizophreniaSex-specific associations between peripheral oxytocin and emotion perception in schizophrenia.Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia.Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia.Endogenous oxytocin levels are associated with the perception of emotion in dynamic body expressions in schizophrenia.Efficacy of oxytocin administration early after psychotrauma in preventing the development of PTSD: study protocol of a randomized controlled trial.Oxytocin and social cognition in affective and psychotic disorders.Efficacy and safety of oxytocin augmentation therapy for schizophrenia: an updated systematic review and meta-analysis of randomized, placebo-controlled trials.Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles.Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders.Peripheral vasopressin but not oxytocin relates to severity of acute psychosis in women with acutely-ill untreated first-episode psychosis.Characterization of the effects of oxytocin on fear recognition in patients with schizophrenia and in healthy controls.The impact of a single administration of intranasal oxytocin on the recognition of basic emotions in humans: a meta-analysis.Adapting social neuroscience measures for schizophrenia clinical trials, Part 1: ferrying paradigms across perilous waters.Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trialThe Potential of Nasal Oxytocin Administration for Remediation of Autism Spectrum Disorders.A meta-analysis and theoretical critique of oxytocin and psychosis: prospects for attachment and compassion in promoting recovery.Brain circuit dysfunction in a distinct subset of chronic psychotic patients.A Review of Oxytocin's Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia.Intranasal Oxytocin May Improve High-Level Social Cognition in Schizophrenia, But Not Social Cognition or Neurocognition in General: A Multilevel Bayesian Meta-analysis.Oxytocin and Social Cognitions in Schizophrenia: A Systematic Review.Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.Increased Serum and Urinary Oxytocin Concentrations after Nasal Administration in Beagle Dogs.Oxytocin and oxytocin receptor gene polymorphisms and risk for schizophrenia: a case-control study.
P2860
Q26770469-E8B0D793-5455-478C-8A71-95DB62B5C5F5Q26863704-E05ADF30-786A-411B-8763-92F068326E4BQ26997373-C2F8C046-FDF9-410F-BA87-11DE98CB1582Q27022926-FF3296DB-CFCD-461B-84C4-79ABEF1FF0E1Q27320111-613658ED-FE6F-4081-9042-E117A8CA4AFFQ30408983-3848FEF7-4AF0-4FDE-B220-907D7D84A2B4Q30453929-8CC44A83-1F1F-4C19-80B4-53E4680E6F88Q30573136-01E11C80-9B01-46F5-870C-417D5CF423FFQ33761384-AEA8B6B3-FB8A-4800-B436-9918C6447772Q33923629-BDE62950-3058-4831-9EF1-AE2FA3A305A3Q33994774-C8388AF7-5699-4C34-982F-5C9C55CAB1F9Q34322999-E5986F0C-9B23-4310-9E44-246CB67181C5Q34425122-DC6D8FB1-F917-4831-ACE7-AF172354F0EDQ34532471-8E2A4D13-3F2E-4BD4-8698-568407B870FDQ34657990-C7C99C8C-623E-457D-A88A-DEE52D3EBD7AQ34675809-67645FCE-EA1B-49D5-8D4A-30E6366FF730Q34790823-8FF08E2F-A68E-41B8-B9A3-0F1C5B0E54FDQ35115758-9482971D-F538-42FC-B3F0-DB72D1C9551AQ35116515-73A2A4CF-2D13-4C6C-8C15-576A1DE44828Q35117441-E5E0C447-9263-43FC-801A-64CC75C3C687Q35118062-53E1DCAC-4A96-4270-8298-B0715662AB5BQ35134420-BAC5FD83-6354-4788-A8AD-321BCE95E8A1Q35646296-7DF17415-B06C-4E86-8279-56B2886959E6Q35754102-317D08EC-7ED9-4FAB-8FCE-1D436FB9D6FAQ36565398-11497F75-80DF-4C54-9FE8-E1A1FFD4D4D8Q36685572-65DDBBC8-C362-46A8-AAFA-C0F4FE9923DFQ36756329-CD76CC69-E28D-47D6-B1E7-29404A4A61CEQ37022856-6AD84E5A-4055-4E23-A2C8-ADA6A37BD2C8Q37103367-50F84658-5C0A-418C-8587-CB0E890D0B75Q37228362-981B08FB-90B2-4987-9498-7BAC5BD5E06AQ37254559-A213BB26-5ED5-44D0-94E2-340CC3343C7DQ37367588-129F9B3A-E55F-43B7-8498-C17083A46E75Q38192728-069183BA-FEFA-43CB-B010-DDEEC345439CQ38226241-11ACE430-AB12-4E95-8CCA-445DF51A5CF3Q38593718-3C47F726-BD5B-45FD-925B-977449766EE3Q38674187-F5E3778C-D166-4D46-80AF-126E70F61877Q38675134-937A3380-7C96-482A-86AB-C25E14F2D3E9Q38683538-110ED10A-B33F-42D4-8D2D-33EA0A5D217EQ41453099-440FCB21-86CE-4506-80E6-E6B10B73CDECQ43578957-1897DBC4-F8C0-45EB-A587-E43DA151C62E
P2860
Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Divergent effects of two diffe ...... s with and without polydipsia.
@en
Divergent effects of two diffe ...... s with and without polydipsia.
@nl
type
label
Divergent effects of two diffe ...... s with and without polydipsia.
@en
Divergent effects of two diffe ...... s with and without polydipsia.
@nl
prefLabel
Divergent effects of two diffe ...... s with and without polydipsia.
@en
Divergent effects of two diffe ...... s with and without polydipsia.
@nl
P2093
P2860
P1433
P1476
Divergent effects of two diffe ...... s with and without polydipsia.
@en
P2093
Alexandrina M Gomes
C S Carter
Morris B Goldman
P2860
P2888
P304
P356
10.1007/S00213-011-2193-8
P577
2011-02-09T00:00:00Z